November 14, 2019
FDA: Class I recall of Zimmer Biomet’s ROSA Brain 3.0 Robotic Surgery System
Editor's Note
The Food & Drug Administration on November 7 identified the recall by Zimmer Biomet of its ROSA Brain 3.0 Robotic Surgery System as Class I, the most serious.
The recall was initiated because of a software issue that incorrectly positions the robotic arm. The company has received five complaints related to this issue, including one patient injury. No deaths have been reported.
Distribution dates for the system were April 8, 2016, to March 19, 2019.
Free Daily News
- HHS report highlights cost, access, quality concerns with private equity in healthcare
- Study: Racial, gender disparities persist in bariatric surgery
- Study: Dry eye risks complicate cataract surgery recovery
- Study: Observational learning ineffective in ensuring nursing student infection control compliance
- Students innovate to reduce OR plastic waste
- OR Business Management Conference 2025 features fresh perspectives, new tracks
- Survey: Bariatric surgery’s fertility benefits not widely understood
- Study highlights nurse staffing disparity in hospitals serving black populations
- Joint Commission issues new workplace violence prevention standards
- AI outperforms experts in ovarian cancer ultrasound detection
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement